• Connective tissue disorders
• Pathophysiology, triggers and treatment of SLE
• Use of serology in SLE
• Limited cutaneous systemic sclerosis • Diffuse cutaneous systemic sclerosis
• Sjogren's syndrome
• Dermatomyositis
• The autoimmune profile
• Lung fibrosis in rheumatological conditions
• Kidney damage in connective tissue disease
• Movement disorders
• Postural, resting and intention tremors
• Dystonia
• Athetosis
• Myoclonus
• Chorea
• Parkinsonism
• Parkinson’s disease
• Parkinson’s Plus • Wilson’s disease
• Huntington's disease
• Fibrotic lung disease
• TLCO / DLCO
• Upper lobe vs. Lower lobe
• PFT's
• Anomalies in transfer factor values
• Restrictive lung disease
• Drugs causing lung fibrosis
• EAA vs. CFA
• Rheumatological diseases and the lung
• Hepatitic blood picture
• Cholestatic blood picture
• Liver enzymes
• Primary biliary cirrhosis • Primary sclerosing cholangitis
• Primary prevention of oesophageal varices
• Hepatitis B serology
• Treatment of viral hepatitis
• Treatment of variceal bleed
• Ascites causes and diagnostic tests
• Lung cancers
• Paraneoplastic syndromes
• Staging of NSCLC and SCLC
• Criteria precluding surgery in NSCLC
• Aetiology of pleural effusions
• Light's criteria
• Cavitating infections
• Sites of lung cancer
• Myasthenia gravis and Lambert Eaton myasthenic syndrome
• Paraneoplastic disorders
• Edrophonium (tensilon test)
• Causes of autonomic neuropathy
• Features of autonomic neuropathy
• Cholinergic crisis
• Myasthenic crisis
• Characteristic EMG findings
